Abstract
Conflicts of interest C.A.M. has acted as an adviser, lecturer and/or researcher for Galderma, Janssen and Leo Pharma. Impressive response rates have been observed following the use of topical photodynamic therapy (PDT) in acne, but the treatment remains little used in practice compared with its established indications in nonmelanoma skin cancer. Why? Therapy‐induced pain, erythema, sterile pustular reactions and hyperpigmentation, as well as the need for multiple treatments, have so far limited patient enthusiasm for PDT in acne. PDT, the interaction of a photosensitizer, light and oxygen to promote a targeted therapeutic effect, can promote improvement in acne via antibacterial activity against Propionibacterium acnes, as well as selective damage to sebaceous glands, reduction in follicular obstruction by keratinocyte shedding and via secondary host responses.1Propionibacterium acnes naturally produces small amounts of certain porphyrins, especially coproporphyrin III, hence the beneficial effects observed in light‐only studies, but application of an additional exogenous photosensitizer is necessary to maximize the effect of PDT in acne, facilitating its use even in moderate‐to‐severe disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.